
Deborah D. Jones
Examiner (ID: 10325)
| Most Active Art Unit | 1108 |
| Art Unit(s) | 1108, 1775, 1751, 1724, 1755 |
| Total Applications | 898 |
| Issued Applications | 776 |
| Pending Applications | 31 |
| Abandoned Applications | 91 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19543444
[patent_doc_number] => 20240360480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => MARINE-DERIVED NANOSELENIUM-PRODUCING STRAIN AND METHOD FOR PREPARING NANOSELENIUM BY USING STRAIN
[patent_app_type] => utility
[patent_app_number] => 18/771445
[patent_app_country] => US
[patent_app_date] => 2024-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18771445
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/771445 | MARINE-DERIVED NANOSELENIUM-PRODUCING STRAIN AND METHOD FOR PREPARING NANOSELENIUM BY USING STRAIN | Jul 11, 2024 | Pending |
Array
(
[id] => 19318624
[patent_doc_number] => 20240240167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => Modified Enzyme and Method of Producing Imidazole Dipeptide Using Same
[patent_app_type] => utility
[patent_app_number] => 18/618330
[patent_app_country] => US
[patent_app_date] => 2024-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18618330
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/618330 | Modified enzyme and method of producing imidazole dipeptide using same | Mar 26, 2024 | Issued |
Array
(
[id] => 18808642
[patent_doc_number] => 20230382976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => APTAMER ASSEMBLIES FOR PROTEIN CROSSLINKING
[patent_app_type] => utility
[patent_app_number] => 18/313064
[patent_app_country] => US
[patent_app_date] => 2023-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18313064
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/313064 | APTAMER ASSEMBLIES FOR PROTEIN CROSSLINKING | May 4, 2023 | Pending |
Array
(
[id] => 19464153
[patent_doc_number] => 20240317822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => PREPARATION OF ISOELECTRICALLY PRECIPITATED SUNFLOWER PROTEIN PRODUCTS WITH IMPROVED COLOUR
[patent_app_type] => utility
[patent_app_number] => 18/189530
[patent_app_country] => US
[patent_app_date] => 2023-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18189530
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/189530 | PREPARATION OF ISOELECTRICALLY PRECIPITATED SUNFLOWER PROTEIN PRODUCTS WITH IMPROVED COLOUR | Mar 23, 2023 | Pending |
Array
(
[id] => 20142454
[patent_doc_number] => 12376767
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Computer system and method for blood gas analysis support
[patent_app_type] => utility
[patent_app_number] => 18/172053
[patent_app_country] => US
[patent_app_date] => 2023-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 49
[patent_no_of_words] => 13252
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 321
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18172053
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/172053 | Computer system and method for blood gas analysis support | Feb 20, 2023 | Issued |
Array
(
[id] => 18498624
[patent_doc_number] => 20230221334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => ANTIBODY MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 18/154386
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18154386
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/154386 | ANTIBODY MANUFACTURE | Jan 12, 2023 | Abandoned |
Array
(
[id] => 18676803
[patent_doc_number] => 20230314435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => MARKER OF CALCIUM-OVERLOAD-MEDIATED NEURONAL DEATH AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/053399
[patent_app_country] => US
[patent_app_date] => 2022-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053399
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/053399 | MARKER OF CALCIUM-OVERLOAD-MEDIATED NEURONAL DEATH AND APPLICATION THEREOF | Nov 7, 2022 | Abandoned |
Array
(
[id] => 18093384
[patent_doc_number] => 20220411725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => CLEANING OR TREATMENT COMPOSITIONS CONTAINING NUCLEASE ENZYMES
[patent_app_type] => utility
[patent_app_number] => 17/845163
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845163
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/845163 | CLEANING OR TREATMENT COMPOSITIONS CONTAINING NUCLEASE ENZYMES | Jun 20, 2022 | Pending |
Array
(
[id] => 17807787
[patent_doc_number] => 20220259622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => CONSTRUCTION METHOD AND RECOMBINANT YEAST STAIN YARROWIA LIPOLYTICA FOR XYLITOL SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 17/737012
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737012
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737012 | CONSTRUCTION METHOD AND RECOMBINANT YEAST STAIN YARROWIA LIPOLYTICA FOR XYLITOL SYNTHESIS | May 3, 2022 | Abandoned |
Array
(
[id] => 18271969
[patent_doc_number] => 20230093211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => THERAPEUTIC USE OF P75NTR NEUROTROPHIN BINDING PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/659991
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17659991
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/659991 | THERAPEUTIC USE OF P75NTR NEUROTROPHIN BINDING PROTEIN | Apr 19, 2022 | Pending |
Array
(
[id] => 20371270
[patent_doc_number] => 12478685
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Methods and kits for identifying subjects responsive to arginine deprivation therapy
[patent_app_type] => utility
[patent_app_number] => 18/038606
[patent_app_country] => US
[patent_app_date] => 2022-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3701
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18038606
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/038606 | Methods and kits for identifying subjects responsive to arginine deprivation therapy | Apr 13, 2022 | Issued |
Array
(
[id] => 17688119
[patent_doc_number] => 20220195411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => ENGINEERED BETA-GLUCOSIDASES AND GLUCOSYLATION METHODS
[patent_app_type] => utility
[patent_app_number] => 17/688458
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17688458
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/688458 | ENGINEERED BETA-GLUCOSIDASES AND GLUCOSYLATION METHODS | Mar 6, 2022 | Abandoned |
Array
(
[id] => 17913561
[patent_doc_number] => 20220315956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => RECOMBINANT HOST CELLS AND METHODS FOR THE PRODUCTION OF L-LACTIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/651720
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23639
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17651720
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/651720 | RECOMBINANT HOST CELLS AND METHODS FOR THE PRODUCTION OF L-LACTIC ACID | Feb 17, 2022 | Abandoned |
Array
(
[id] => 17611544
[patent_doc_number] => 20220153823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => METHOD TO PRODUCE A HIGHLY CONCENTRATED IMMUNOGLOBULIN PREPARATION FOR SUBCUTANEOUS USE
[patent_app_type] => utility
[patent_app_number] => 17/589519
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17589519
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/589519 | Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use | Jan 30, 2022 | Issued |
Array
(
[id] => 17611881
[patent_doc_number] => 20220154160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => ENGINEERED BOTULINUM NEUROTOXIN
[patent_app_type] => utility
[patent_app_number] => 17/582958
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27366
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17582958
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/582958 | Engineered botulinum neurotoxin | Jan 23, 2022 | Issued |
Array
(
[id] => 18955493
[patent_doc_number] => 20240043820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => ENZYME VARIANTS
[patent_app_type] => utility
[patent_app_number] => 18/266385
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266385
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266385 | ENZYME VARIANTS | Dec 12, 2021 | Pending |
Array
(
[id] => 18955497
[patent_doc_number] => 20240043824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => MULTIMERIC PROTEINS OF THE PEROXIREDOXIN FAMILY AS SCAFFOLD PROTEINS
[patent_app_type] => utility
[patent_app_number] => 18/266109
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266109
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266109 | MULTIMERIC PROTEINS OF THE PEROXIREDOXIN FAMILY AS SCAFFOLD PROTEINS | Dec 9, 2021 | Pending |
Array
(
[id] => 20316133
[patent_doc_number] => 12454677
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Methods for the maturation of cardiomyocytes on amniotic fluid cell-derived ECM, cellular constructs, and uses for cardiotoxicity and proarrhythmic screening of drug compounds
[patent_app_type] => utility
[patent_app_number] => 17/531402
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 42
[patent_no_of_words] => 41256
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17531402
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/531402 | Methods for the maturation of cardiomyocytes on amniotic fluid cell-derived ECM, cellular constructs, and uses for cardiotoxicity and proarrhythmic screening of drug compounds | Nov 18, 2021 | Issued |
Array
(
[id] => 20744208
[patent_doc_number] => 12644104
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-02
[patent_title] => Detection of environmental influences by bioluminescence
[patent_app_type] => utility
[patent_app_number] => 18/028315
[patent_app_country] => US
[patent_app_date] => 2021-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 4852
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18028315
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/028315 | Detection of environmental influences by bioluminescence | Nov 2, 2021 | Issued |
Array
(
[id] => 18844910
[patent_doc_number] => 20230407314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => ANAEROBIC CO-PRODUCTION OF ESSENTIAL AMINO ACIDS, ALCOHOLS AND LIPIDS FROM MOLASSES, HYDROLYSED STARCH AND LIGNOCELLULOSE
[patent_app_type] => utility
[patent_app_number] => 18/035068
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17300
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035068
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035068 | ANAEROBIC CO-PRODUCTION OF ESSENTIAL AMINO ACIDS, ALCOHOLS AND LIPIDS FROM MOLASSES, HYDROLYSED STARCH AND LIGNOCELLULOSE | Nov 1, 2021 | Pending |